Investment analysts at StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Free Report) in a research report issued on Tuesday. The firm set a “hold” rating on the biotechnology company’s stock.
Calithera Biosciences Stock Performance
NASDAQ:CALA opened at $0.00 on Tuesday. The firm’s 50-day moving average is $0.02 and its 200-day moving average is $0.02. Calithera Biosciences has a 52-week low of $0.00 and a 52-week high of $0.12.
About Calithera Biosciences
Featured Stories
- Five stocks we like better than Calithera Biosciences
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Taiwan Semiconductor Stock: Buy Now or Wait for Earnings?
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
- How to Find Undervalued Stocks
- Citigroup Faces Growing Troubles: Could the Industry Be at Risk?
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.